Phosphoenolpyruvate carboxylase mutant, enzymatic activity improving method and application

Through directional evolution and high-throughput screening technology, the activity of phosphoenol pyruvate carboxylase in E. coli was improved, the problem of insufficient PEPC enzyme activity was solved, and the efficient production of succinic acid was achieved.

CN118995774APending Publication Date: 2024-11-22CHONGQING UNIV

Patent Information

Application Number
CN202411407669.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-10
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

The lack of phosphoenol pyruvate carboxylase (PEPC) enzyme activity in the succinic acid biosynthesis limits the improvement of succinic acid production efficiency and is difficult to meet the high standard needs of industrial production.

Method used

The targeted evolution strategy was used to combine error-prone PCR technology and high-throughput screening method to screen mutants of cyanobacteria-derived PEPC enzymes, and the mutants were expressed in E. coli through the recombinant plasmid pTrc99A vector to improve the activity of PEPC enzymes.

Benefits of technology

It significantly improves the activity of PEPC enzymes, overcomes the bottleneck problem of low enzyme activity, improves the production efficiency and output of succinic acid, and meets the needs of industrial production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118995774A_ABST
    Figure CN118995774A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of gene engineering, and particularly relates to a phosphoenolpyruvate carboxylase mutant, an enzymatic activity improving method and application. The mutation sites of the phosphoenolpyruvate carboxylase mutant are as follows: D210G, L406P and V886A. The enzyme activity improving method comprises the following steps: carrying out error-prone PCR (Polymerase Chain Reaction) amplification by taking a recombinant plasmid pTrc99A-pepc0 as a template, connecting a carrier, and transferring into escherichia coli DC1515 to obtain a mutant library of a succinic acid high-yield strain; sequentially carrying out liquid culture fermentation and single droplet wrapping on strains in the mutant library, carrying out Raman laser droplet sorting, carrying out microwell plate fermentation screening, and carrying out shake flask re-screening, so as to obtain the phosphoenolpyruvate carboxylase mutant with high succinic acid yield. The invention provides an innovative and efficient path for improving the PEPC enzyme activity, and opens up a new possibility for enzyme application in industrial production.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of genetic engineering, and specifically relates to a phosphoenolpyruvate carboxylase mutant and an enzyme activity improvement method and application. Background Art

[0002] Succinic acid, also known as succinic acid, is a C4 compound containing two carboxylic acids and is also an important metabolic intermediate in the tricarboxylic acid cycle process in organisms. As a core intermediate in the tricarboxylic acid cycle and a key end product of anaerobic fermentation, its biosynthesis process cleverly combines the fixation and efficient utilization of carbon dioxide, opening up new horizons for exploring innovative technologies for greenhouse gas emission reduction. As a valuable C4 platform compound, succinic acid shows great potential as a precursor for a variety of high-value organic compounds, including but not limited to 1,4-butanediol, γ-butyrolactone, tetrahydrofuran, adipic acid, N-methylpyrrolidone, linear aliphatic esters and biodegradable plastics (such as PBS); therefore, it is widely used in many fields such as food industry, pharmaceutical manufacturing and chemical industry, greatly enriching its market application value.

[0003] At present, the industrial production path of succinic acid has gradually transformed from traditional chemical synthesis and electrochemical methods to more environmentally friendly biomass fermentation methods. Traditional chemical methods have defects such as complex operating procedures and harsh reaction conditions, which are difficult to meet the urgent needs of sustainable development. The biosynthesis method, with its unique advantages of utilizing renewable energy and directly converting carbon dioxide into products, is not only cost-effective, but also achieves zero pollution in the production process. Therefore, it is widely used in the industrial production of succinic acid.

[0004] In the efficient biofactory of Escherichia coli, the biosynthesis of succinate is closely dependent on the fine regulation of the tricarboxylic acid cycle, especially the catalytic action of the key enzyme phosphoenolpyruvate carboxylase (PEPC). PEPC initiates the key step of succinate synthesis by catalyzing the conversion of phosphoenolpyruvate (PEP) to oxaloacetate, and then completes the synthesis of succinate through relay catalysis of malate dehydrogenase and fumarate synthase. However, the current expression system based on Escherichia coli faces the challenge of insufficient PEPC enzyme activity, which limits the improvement of production efficiency.

[0005] In the prior art, patent CN102533626A discloses a genetically engineered strain for producing succinic acid from glucose and a fermentation method for producing acid therefrom. The patent uses a strain of Escherichia coli lacking the activity of the lactate dehydrogenase gene and the pyruvate formate lyase gene as a starting strain, and utilizes homologous recombination technology to knock out the phosphoenolpyruvate carboxylase gene, and over-co-express phosphoenolpyruvate carboxyl kinase and nicotinic acid phosphoribosyl transferase, thereby improving the synthesis efficiency of succinic acid.

[0006] Patent CN103131663B discloses a recombinant bacterium and a construction method for increasing the production of succinic acid. The invention uses constitutive regulatory elements with different expression intensities to respectively regulate the expression of the ppc and pck genes of E. coli, thereby increasing the activity of phosphoenolpyruvate carboxylase PPC and phosphoenolpyruvate carboxyl kinase PCK in E. coli or its mutant strains, thereby increasing the production and conversion rate of succinic acid in E. coli. Summary of the invention

[0007] In view of this, the present invention provides a method for improving the activity of phosphoenolpyruvate carboxylase, as well as a recombinant plasmid for assisting the production of succinate and a phosphoenolpyruvate carboxylase mutant with high succinate production. The present invention focuses on PEPC enzymes from cyanobacteria, and through the implementation of a directed evolution strategy, and the integration of error-prone PCR technology and an efficient high-throughput screening method, a mutant strain with significantly improved enzyme activity is accurately screened, thereby overcoming the bottleneck problem that the current PEPC enzyme activity is low and difficult to meet the high standards of industrial production.

[0008] One of the purposes of the present invention is to provide a recombinant plasmid that assists in producing succinic acid, thereby providing support for the subsequent screening of mutant strains with high enzyme activity.

[0009] To achieve the above object, the present invention adopts the following technical solutions:

[0010] A recombinant plasmid assisting in the production of succinic acid, wherein the recombinant plasmid is a pTrc99A vector carrying a pepc fragment; the nucleotide sequence of the pepc fragment is shown in SEQ ID NO: 1.

[0011] Furthermore, the nucleotide sequence of the recombinant plasmid is shown in SEQ ID NO:2.

[0012] Furthermore, the PEPC is derived from cyanobacteria.

[0013] Furthermore, the recombinant plasmid is prepared by the following method:

[0014] 1) Extracting genomic DNA from cyanobacteria;

[0015] 2) Using the total DNA of the cyanobacteria extracted in step 1) as a template for PCR amplification, the PCR amplification product was purified by agarose gel electrophoresis and gel cutting, and then ligated with the vector pTrc99A by double restriction digestion; the ligation product pTrc99A-pepc 0 Transformed into E. coli DH5α competent cells to obtain the recombinant plasmid pTrc99A-pepc 0 .

[0016] Further, in step 2), the PCR amplification primers include an upstream primer pepc-F1 and a downstream primer pepc-R1, the nucleotide sequence of pepc-F1 is shown in SEQ ID NO:4, and the nucleotide sequence of pepc-R1 is shown in SEQ ID NO:5.

[0017] Furthermore, the PCR amplification reaction procedure was as follows: step one: 94°C for 5 min, one cycle; step two: 94°C for 30 s; 55°C for 30 s; 72°C for 3 min; 30 cycles; step three: 72°C for 10 min; one cycle.

[0018] The second object of the present invention is to provide a phosphoenolpyruvate carboxylase mutant obtained by using the aforementioned recombinant plasmid, which provides support for the subsequent efficient production of succinic acid.

[0019] To achieve the above object, the present invention adopts the following technical solutions:

[0020] The phosphoenolpyruvate carboxylase mutant was obtained using the aforementioned recombinant plasmid.

[0021] Furthermore, the phosphoenolpyruvate carboxylase mutant uses the amino acid sequence of phosphoenolpyruvate carboxylase as a reference sequence, and the following amino acid sites are mutated: D210G, L406P, V886A; the amino acid sequence of the phosphoenolpyruvate carboxylase is shown in SEQ ID NO: 8.

[0022] Furthermore, the phosphoenolpyruvate carboxylase is numbered as Nostoc sp. PCC 7120 in NCBI.

[0023] Furthermore, the nucleotide sequence of the phosphoenolpyruvate carboxylase mutant is shown in SEQ ID NO: 3 in the sequence listing.

[0024] A third object of the present invention is to provide a method for improving the activity of phosphoenolpyruvate carboxylase.

[0025] To achieve the above object, the present invention adopts the following technical solutions:

[0026] A method for increasing the activity of phosphoenolpyruvate carboxylase comprises the following steps:

[0027] (1) using the aforementioned recombinant plasmid as a template for error-prone PCR amplification, connecting the vector and transforming into Escherichia coli DC1515 to obtain a mutant library of a succinic acid high-producing strain;

[0028] (2) The strains in the mutant library obtained in step (1) are subjected to liquid culture fermentation and single droplet encapsulation, Raman laser droplet sorting, microplate fermentation screening, and shake flask screening in sequence to obtain phosphoenolpyruvate carboxylase mutants with high succinate production.

[0029] Furthermore, in step (1), the primers for the error-prone PCR amplification include an upstream primer pepc-F2 and a downstream primer pepc-R2, the nucleotide sequence of pepc-F2 is shown in SEQ ID NO: 6, and the nucleotide sequence of pepc-R2 is shown in SEQ ID NO: 7.

[0030] Furthermore, in step (1), the error-prone PCR reaction conditions are: MgCl2: 2-10 mM; MnCl2: 0-1 mM; more preferably MgCl2: 5 mM; MnCl2: 0.1 mM.

[0031] Furthermore, in step (1), the error-prone PCR reaction procedure includes: the first step: 95°C, 2 min; 94°C, 30 s; 1 cycle; the second step: 50°C-65°C, 1 min; 72°C, 1 kb / min, 16-25 cycles; the third step: 72°C, 7 min; 1 cycle.

[0032] Furthermore, in step (1), the vector is pTrc99A.

[0033] Furthermore, in step (1), the purified product was ligated with the vector pTrc99A by homologous recombination, with the molar ratio of vector to fragment being 2:1, and the reaction was carried out at 50° C. for 15 min.

[0034] Furthermore, in step (1), the Escherichia coli DC1515 is a strain in which the genes of lactate dehydrogenase (ldhA), pyruvate formate lyase (plfA), and glucose transporter (ptsG) of wild-type Escherichia coli are knocked out.

[0035] Furthermore, in step (2), the liquid culture fermentation includes: adding the strain mutant library to LB liquid culture medium and incubating at 37°C for 5 hours, then adding inducer IPTG and substrate glucose for induction and fermentation, inducing fermentation for 10 hours, and the fermentation temperature is 37°C.

[0036] Further, in step (2), the single droplet encapsulation includes: subjecting the fermented strain to ultrasonic dispersion treatment for 5 minutes, and the initial cell concentration of the droplet encapsulation is OD 600 =0.5, the external phase is fluorinated oil containing surfactant, and the internal phase is a mixture of LB medium and hydrogel.

[0037] Furthermore, in step (2), the Raman laser signal comparison method is selected from one or more of the following combinations: single peak comparison, multi-peak comparison, and full spectrum comparison; the signal detection unit includes a dielectric capture unit for capturing cells / particles by dielectric means to extend the Raman laser signal acquisition time and improve the acquisition signal intensity.

[0038] Furthermore, in step (2), the microplate fermentation conditions are LB medium with a pH of 7.5, a substrate glucose concentration of 15 g / L, a temperature of 37° C., a shaking speed of 200 rpm, and a fermentation time of 24 h.

[0039] Further, step (2) specifically includes the following steps:

[0040] S1: liquid culture fermentation and single droplet encapsulation of the strains in the mutant library of the high-yielding succinic acid strain obtained in step (1);

[0041] S2: Combine Raman laser detection with the concentration of succinic acid in the droplets in S1, perform microfluidic sorting according to the intensity of the succinic acid signal in the droplets, screen out one or several droplets with relatively high succinic acid concentration, and obtain the Class I Escherichia coli engineered strain ASI-X with high succinic acid production;

[0042] S3: The Class I Escherichia coli engineered strain ASI-X obtained in S2 was subjected to microtiter plate fermentation screening, and combined with the mixed indicator color development reaction, the Class II Escherichia coli engineered strain ASII-X with a higher succinic acid production was screened;

[0043] S4: The Class II Escherichia coli engineered strain ASII-X obtained in S3 was subjected to shake flask fermentation, and the supernatant was processed and the fermentation yield was verified by high performance liquid chromatography to obtain a succinic acid high-yielding strain ASIII;

[0044] S5: The high-yield succinic acid strain ASIII obtained in S4 was induced by shaking flask culture, the bacteria were ultrasonically disrupted, and the changes in protein expression were analyzed by polyacrylamide gel electrophoresis. The effects of the mutant base sites and amino acid sites on protein expression and enzyme activity were analyzed.

[0045] Further, in S3, the mixed indicator is composed of one part of neutral red indicator and one part of 0.1% bromothymol blue, and the color change range is pH 7.0 (rose) to 7.2 (light red) to 7.4 (blue-purple); the color development reaction is to react for 2 to 5 minutes after adding the mixed indicator, and the absorbance at 450nm is measured using an enzyme reader. The greater the absorbance, the higher the succinic acid production of the corresponding strain.

[0046] Furthermore, in S4, the conditions for shake flask fermentation are substrate glucose concentration of 15 g / L, basic magnesium carbonate 4%, temperature of 37° C., shaker speed of 200 rpm, and fermentation time of 72 h.

[0047] Furthermore, in S4, the supernatant is treated by diluting 10 times with ultrapure water, filtering with a 0.22 μm aqueous membrane, and then ultrasonicating for 15 minutes.

[0048] Further, in S4, the chromatographic conditions of the high performance liquid chromatography include: using an Agilent ZorbaxEclipse XDB C18 chromatographic column, mobile phase A is methanol, mobile phase B is KH2PO4 with a concentration of 10 mM and a pH of 2.8, and mobile phase A and mobile phase B are isocratically eluted at a volume ratio of 5:95; the detection wave is 210 nm.

[0049] Furthermore, the high performance liquid chromatography method can also simultaneously detect three other by-products of the fermentation process: malic acid, citric acid, and lactic acid.

[0050] Furthermore, the shake flask verification medium volume in S4 was 50 mL and the inoculum size was 1%

[0051] A fourth object of the present invention is to provide a use of the aforementioned recombinant plasmid and / or the aforementioned phosphoenolpyruvate carboxylase mutant in the preparation of a product for improving the activity of phosphoenolpyruvate carboxylase.

[0052] A fifth object of the present invention is to provide a use of the aforementioned recombinant plasmid and / or the aforementioned phosphoenolpyruvate carboxylase mutant in the preparation of a product for producing succinic acid.

[0053] The beneficial effects of the present invention are:

[0054] 1. The present invention cleverly combines directed evolution technology (error-prone PCR) with high-throughput screening strategy, opening up a new path for the directed transformation and efficient screening of PEPC enzyme activity. Error-prone PCR technology constructs a huge mutant library by introducing random mutations, providing a rich genetic variation resource for the improvement of enzyme activity. High-throughput screening technology accurately identifies phosphoenolpyruvate carboxylase with significantly high enzyme activity from a huge mutant library. The method of the present invention not only significantly improves the screening efficiency, but also accelerates the discovery and industrial application process of new and efficient PEPC enzymes, injecting strong power into the green and efficient production of succinic acid.

[0055] 2. The present invention identifies the base mutation sites that have a key promoting effect on PEPC enzyme activity: D210G, L406P, V886A. The phosphoenolpyruvate carboxylase mutant provided by the present invention has significantly improved enzyme activity, successfully overcoming the problem of insufficient PEPC enzyme activity in the current expression system based on Escherichia coli, and is of great significance for improving the production efficiency and yield of succinic acid. BRIEF DESCRIPTION OF THE DRAWINGS

[0056] Figure 1 Flow chart for high-throughput screening of strains with high phosphoenolpyruvate carboxylase activity;

[0057] Figure 2 Plasmid pTrc99A-pepc 0 Schematic diagram of the construction process;

[0058] Figure 3 This is the standard Raman spectrum of succinic acid. DETAILED DESCRIPTION

[0059] The technical solution of the present invention will be further described clearly and completely in conjunction with specific embodiments below. Obviously, the described embodiments are only part of the embodiments of the present invention, rather than all the embodiments. Therefore, based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative work belong to the protection scope of the present invention.

[0060] In the embodiment of the present invention, the competent E. coli DH5α was purchased from Beijing Qingke Biotechnology Co., Ltd.; the E. coli expression vector was stored in this laboratory; E. coli DC1515 is a strain in which the wild-type E. coli lactate dehydrogenase (ldhA), pyruvate formate lyase (plfA), and glucose transporter (ptsG) genes are knocked out, and has the potential to produce succinate by fermentation, and was donated by Professor P. Clark of Southern Illinois University in the United States. The E. coli DC1515 was specifically obtained by the following gene editing method: DC1515 [pfl A::Cam ldh A::Tn10 pts G400::Kan in W1485].

[0061] In the examples of the present invention, BamHI, HindIII, and a plasmid extraction kit were purchased from Tiangen Biochemical Technology Co., Ltd., a gel recovery kit was purchased from Beijing Zhuangmeng Biogene Technology Co., Ltd., and a random mutagenesis kit based on error-prone PCR amplification was purchased from Beijing Tianenze Gene Technology Co., Ltd.

[0062] In the embodiments of the present invention, the primers involved were synthesized by Chongqing Branch of Beijing Qingke Co., Ltd.

[0063] In the embodiment of the present invention, the construction flow chart of high-throughput screening of phosphoenolpyruvate carboxylase (PEPC) high enzyme activity strain is as follows: Figure 1As shown. The present invention focuses on the directed evolution strategy of phosphoenolpyruvate carboxylase (PEPC) from cyanobacteria, and constructs a PEPC mutant library by introducing error-prone PCR technology. Then, microdroplet high-throughput sorting technology is used for preliminary screening; and re-screening is performed through 24-well plate fermentation; finally, through shake flask fermentation rescreening, strains that can significantly increase the production of succinic acid are accurately identified from the huge mutant library. Then, for these mutant strains with high enzyme activity, sequence analysis is further performed to confirm the base mutation sites that have a key promoting effect on the PEPC enzyme activity. This method can effectively improve the activity of phosphoenolpyruvate carboxylase and realize the directed evolution of PEPC.

[0064] Example 1. Construction of mutant library of succinic acid high-producing strain

[0065] 1. Recombinant plasmid pTrc99A-pepc 0 Construction

[0066] according to Figure 2 The plasmid pTrc99A-pepc was constructed as shown 0 , the specific steps are as follows:

[0067] (1) extracting genomic DNA from cyanobacteria; the nucleotide sequence of the pepc fragment is shown in SEQ ID NO: 1, and the amino acid sequence is shown in SEQ ID NO: 8;

[0068] (2) Using the cyanobacterial genome extracted in step (1) as a template, PCR amplification was performed using primers pepc-F1 and pepc-R1. The PCR amplification product was subjected to 1.0% agarose gel electrophoresis, and the target band of 300 bp-3100 bp was recovered by gel excision purification. The primer information is shown in Table 1, and the PCR amplification reaction procedure is shown in Table 2.

[0069] Table 1. Recombinant plasmid pTrc99A-pepc 0 Primer information table

[0070]

[0071] Table 2. PCR amplification reaction program

[0072]

[0073] (3) The purified product was double-digested and ligated with the vector pTrc99A to form the ligated product pTrc99A-pepc 0 The cells were transformed into competent E. coli DH5α and plated on solid LB plates (100 μg / mL Amp).

[0074] (4) Pick the single colony positive transformant in step (3) and culture it overnight in liquid LB medium to obtain the recombinant plasmid pTrc99A-pepc 0 , whose nucleotide sequence is shown in SEQ ID NO: 2 in the sequence listing.

[0075] 2. Construction of strain mutant library by error-prone PCR

[0076] (1) Error-prone PCR amplification of pepc to construct pTrc99A-pepc 0 Plasmid was used as template, and primers pepc-F2 and pepc-R2 were used for error-prone PCR amplification; the error-prone PCR reaction conditions were: MgCl2: 5mM; MnCl2: 0.1mM. The PCR amplification product was subjected to 1.0% agarose gel electrophoresis, and the gel was cut and purified to recover the target band of 3000bp-3100bp. The primer information of pepc error-prone PCR amplification is shown in Table 3, the reaction system is shown in Table 4, and the reaction procedure is shown in Table 5.

[0077] Table 3. Primer information for error-prone PCR amplification of pepc

[0078]

[0079] Table 4. Error-prone PCR reaction system

[0080]

[0081]

[0082] Table 5. Error-prone PCR reaction schedule

[0083]

[0084] (2) The purified product was homologously ligated with the vector pTrc99A, with a vector-to-fragment molar ratio of 2:1, and the reaction was carried out at 50°C for 15 min. The ligated product pTrc99A-pepc was transformed into competent E. coli DC1515, and all transformants constituted an error-prone PCR mutant library.

[0085] Example 2. High-throughput screening of strains with high phosphoenolpyruvate carboxylase activity

[0086] 1. Optimization of droplet fermentation and single droplet packaging

[0087] (1) The strain mutant library obtained in Example 1 was added to 4 mL of LB liquid culture medium at 37°C and a shaking speed of 180 rpm, and cultured for 5 h until OD 600=0.5, then add 5 μL inducer IPTG (0.5 M) and 1 mL substrate glucose (45 mg / mL) for induction and fermentation. The induction fermentation time is 10 h and the fermentation temperature is 37°C.

[0088] (2) Wash and resuspend the fermented strains and calculate the OD 600 =0.5 was transferred to 5 mL M9 inorganic salt medium and ultrasonicated (total power of the instrument was 950 W, power was 4%, ultrasonication was performed for 8 s, and then stopped for 5 s, for a total of 5 min) to obtain monodispersed post-fermentation mutant library strains. The droplet encapsulation chip was used for single-cell droplet encapsulation. The starting cell concentration of the droplet encapsulation was OD 600 =0.5.

[0089] 2. Raman laser droplet sorting

[0090] (1) Liquid flow convergence: The single-cell droplets to be sorted are converged with the buffer solution to form a stable single-cell droplet flow.

[0091] (2) Signal detection: Generate Raman laser, capture single cells by dielectric method to prolong the Raman laser signal acquisition time, perform Raman laser signal detection on the formed single cell droplets one by one, collect the detection signal and transmit it to the sorting control unit.

[0092] (3) Droplet sorting: Obtain the signal collected in the above signal detection step and Figure 3 The standard Raman spectrum data of succinic acid shown in the figure were fully compared, and the corresponding encapsulated oil-in-water droplets were sorted according to the signal, and the droplets of the required part were collected, thus obtaining the bacterial liquid of 349 Class I Escherichia coli engineered strains ASI-X with high succinic acid production.

[0093] 3. Microplate Fermentation Screening

[0094] (1) The bacterial solution ASI-X collected in step 2 was divided into 1.5 mL centrifuge tubes, with 200 μL in each tube. The solution was centrifuged at 12,000 rpm for 2 min, the supernatant was discarded, and the bacterial solution was spread on LB solid medium with ampicillin resistance and cultured at 37°C for 10 h.

[0095] (2) A single clone colony was selected from the LB plate and inoculated into a 24-well plate containing 1 mL of LB medium (50 μg / mL Amp), with each well corresponding to a specific transformant. The culture was maintained at 37°C and a shaker speed of 180 rpm for 14 h.

[0096] (3) Under sterile conditions, 100 μL of bacterial solution was taken out from the 24-well plate and transferred to 1 mL of LB medium (50 μg / mL Amp, pH 7.5) in a 24-well plate. The temperature was 37°C and the shaking speed was 220 rpm. The culture was carried out for 3 h. IPTG inducer was added, and substrate glucose was added to a concentration of 15 g / L. The temperature was 37°C and the shaking speed was 200 rpm. The fermentation was shaken for 24 h.

[0097] (4) Take 100 μL of the fermentation broth and place it in a 96-well plate. Add 10 μL of the mixed indicator and react for 10 min. Then use an ELISA reader to measure the absorbance OD under 450 nm visible light. 450 , 10 strains with relatively large absorbance were selected to form ASII-X, and a shake flask screening experiment was conducted. Among them, the mixed indicator was composed of one part of neutral red indicator and one part of 0.1% bromothymol blue, and the color change range was pH 7.0 (rose) ~ 7.2 (light red) ~ 7.4 (blue-purple).

[0098] 4. Shake flask rescreening

[0099] (1) The ASII-X strain in step 3 was inoculated into a shake flask containing 50 mL of LB medium at a 1% inoculum size, the temperature was 37° C., the shaker speed was 200 rpm, and the culture was continued for 3 h. IPTG inducer was added, and substrate glucose was added to a concentration of 15 g / L, basic magnesium carbonate was added to a concentration of 4%, the temperature was 37° C., the shaker speed was 200 rpm, and the fermentation was carried out under shaking for 72 h.

[0100] (2) The fermentation broth was centrifuged, the supernatant was diluted 10 times, filtered through a 0.22 μm aqueous membrane, and then sonicated for 15 min.

[0101] (3) The treated supernatant was used to measure the succinic acid concentration by HPLC, and the strain ASIII with the highest yield was obtained. Its concentration was 32.06 g / L, which was higher than that of the control strain DC1515-pTrc99A-pepc 0 Increased by 1.61 times.

[0102] The HPLC detection conditions are as follows:

[0103] The chromatographic column used was Agilent Zorbax Eclipse XDB C18; the mobile phase A was methanol, the mobile phase B was KH2PO4 with a concentration of 10mM and a pH of 2.8, and the volume ratio of mobile phase A to mobile phase B was 5:95; the elution method was isocratic elution; and the detection wavelength was 210nm. This detection method can also simultaneously detect three other byproducts of the fermentation process: malic acid, citric acid, and lactic acid.

[0104] 5. Sequence Analysis

[0105] The strain ASIII with the highest succinic acid production obtained in step 4 was induced by shaking flask culture, the bacteria were ultrasonically disrupted, and the changes in protein expression were analyzed by polyacrylamide gel electrophoresis. The plasmid was extracted with a plasmid extraction kit and sent to Shanghai Biotechnology for sequencing. Sequence analysis was performed to analyze the effects of the mutant base sites and amino acid sites on protein expression and enzyme activity.

[0106] The sequencing results showed that the mutant enzyme gene had three base mutations, namely D210G, L406P, and V886A. The nucleotide sequence of the phosphoenolpyruvate carboxylase mutant constructed by the present invention is shown in SEQ ID NO:3.

Claims

1. Recombinant plasmids that assist in the production of succinic acid, It is characterized in that The recombinant plasmid is a pTrc99A vector carrying a pepc fragment; the nucleotide sequence of the pepc fragment is shown in SEQ ID NO:

1.

2. The recombinant plasmid according to claim 1, It is characterized in that The nucleotide sequence of the recombinant plasmid is shown in SEQ ID NO:

2.

3. A phosphoenolpyruvate carboxylase mutant obtained using the recombinant plasmid according to any one of claims 1 to 2.

4. The phosphoenolpyruvate carboxylase mutant according to claim 3, It is characterized in that The phosphoenolpyruvate carboxylase mutant uses the amino acid sequence of phosphoenolpyruvate carboxylase as a reference sequence, and the following amino acid sites are mutated: D210G, L406P, and V886A; the amino acid sequence of the phosphoenolpyruvate carboxylase is shown in SEQ ID NO:

8.

5. The phosphoenolpyruvate carboxylase mutant according to claim 3, It is characterized in that The nucleotide sequence of the phosphoenolpyruvate carboxylase mutant is shown in SEQ ID NO: 3 in the sequence listing.

6. A method for increasing the activity of phosphoenolpyruvate carboxylase, It is characterized in that The steps include: (1) using the recombinant plasmid described in any one of claims 1 to 2 as a template for error-prone PCR amplification, connecting the vector and transforming into Escherichia coli DC1515 to obtain a mutant library of a succinic acid high-producing strain; (2) The strains in the mutant library obtained in step (1) are subjected to liquid culture fermentation and single droplet encapsulation, Raman laser droplet sorting, microplate fermentation screening, and shake flask screening in sequence to obtain phosphoenolpyruvate carboxylase mutants with high succinate production.

7. The method according to claim 6, It is characterized in that In step (1), the primers for error-prone PCR amplification include an upstream primer pepc-F2 and a downstream primer pepc-R2, the nucleotide sequence of pepc-F2 is shown in SEQ ID NO: 6, and the nucleotide sequence of pepc-R2 is shown in SEQ ID NO:

7.

8. The method according to claim 6, It is characterized in that In step (1), the Escherichia coli DC1515 is a strain in which the genes of lactate dehydrogenase, pyruvate formate lyase and glucose transporter of wild-type Escherichia coli are knocked out.

9. Use of the recombinant plasmid according to any one of claims 1 to 2 and / or the phosphoenolpyruvate carboxylase mutant according to any one of claims 3 to 5 in the preparation of a product for improving the activity of phosphoenolpyruvate carboxylase.

10. Use of the recombinant plasmid according to any one of claims 1 to 2 and / or the phosphoenolpyruvate carboxylase mutant according to any one of claims 3 to 5 in the preparation of a product for producing succinic acid.

Citation Information

Patent Citations

  • Genetic engineering strain for producing succinic acid by utilizing glucose and acidogenic fermentation method thereof

    CN102533626A

  • Recombinant bacteria for increasing yield of succinic acid and construction method thereof

    CN103131663B

Cited By

  • Bi-BDO fermentation pH dissolved oxygen dynamic optimization method based on online Raman spectrum

    CN121034441A